
Experts discuss unmet needs and challenges faced by patients with uveal melanoma. This program was made possible with support from Immunocore.
Experts discuss unmet needs and challenges faced by patients with uveal melanoma. This program was made possible with support from Immunocore.
Nathan L. Scott, M.D., discusses the safety and efficacy of tebentafusp. This program was made possible with support from Immunocore.
Nathan L. Scott, M.D., provides a brief overview of the current guidelines for treatment of metastatic uveal melanoma, as well as what considerations go into choosing the appropriate treatment for it. This program was made possible with support from Immunocore.
Nathan L. Scott, M.D., discusses the risk of recurrence within diagnosed uveal melanoma patients. Uveal Melanoma Prognosis and Risk Stratification
Nathan L. Scott, M.D., details what tests a patient should expect if they wish to confirm a uveal melanoma diagnosis. This program was made possible with support from Immunocore.
Melody Burchett discusses how she educates patients who have been recently diagnosed with uveal melanoma. Resources for Patients With Newly Diagnosed Uveal Melanoma
Melody Burchett discusses her journey with uveal melanoma and the formation of A Cure in Sight. This program was made possible with support from Immunocore.
After a brief introduction, Nathan L. Scott, M.D., gives an overview of uveal melanoma, including the risk factors and ways to help prevent it. This program was made possible with support from Immunocore.
Published: August 23rd 2024 | Updated:
Published: August 23rd 2024 | Updated:
Published: August 23rd 2024 | Updated:
Published: August 23rd 2024 | Updated:
Published: August 23rd 2024 | Updated:
Published: August 23rd 2024 | Updated: